Virax Biolabs specializes in developing advanced immune profiling solutions and T-cell diagnostics, focusing on chronic inflammation and T-cell exhaustion. Their product line includes the ViraxImmune™ platform, which features pathogen-specific peptide pools designed to stimulate T-cell responses effectively. Additionally, they offer ELISpot and FluoroSpot kits that allow for the analysis of immune responses at the cellular level, utilizing pre-coated plates and reagents to measure multiple cytokines. Their high-affinity antibodies are tailored for detecting cytokines and biomarkers in various assays, including ELISA and flow cytometry, enhancing the sensitivity and specificity of T-cell monitoring.

The company emphasizes the importance of immune profiling in understanding both innate and adaptive immune responses, which is crucial for diagnosing viral diseases and developing novel therapeutic strategies. Their ELISpot assays are particularly noted for their ability to identify cells actively secreting signaling proteins or antibodies, achieving a detection limit of 1 in 100,000 cells. This innovative approach not only aids in the diagnosis of conditions like post-acute infection syndrome but also supports ongoing research into T-cell dysfunction and long COVID, positioning Virax Biolabs as a key player in the field of immunology and diagnostics.

United Kingdom

Virax Biolabs is an innovative biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases.

Virax Biolabs

Company Details